A Metal‐Polyphenol‐Based Oxygen Economizer and Fenton Reaction Amplifier for Self‐Enhanced Synergistic Photothermal/Chemodynamic/Chemotherapy
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202300054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Hui Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Anhui Medical University, Hefei, 230032, P. R. China. Hauptthemen laut MEDLINE: Doxorubicin, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
To overcome the limitations of doxorubicin (DOX) chemotherapy, nanomedicines that integrate additional photothermal therapy (PTT) and chemodynamic therapy (CDT) strategies are highlighted as promising alternatives for the treatment of malignant tumors. However, time‐consuming preparation processes, biosafety concerns, and the bottlenecks of individual therapeutic modalities often limit the practical applications of this strategy. To address these issues, this work designs an oxygen economizer that additionally serves as a Fenton reaction amplifier through the simple assembly of epigallocatechin gallate (EGCG), pluronic F‐127 (PF127), iron (III) ions, and doxorubicin (DOX) for the enhancement of synergistic PTT/CDT/chemotherapy. The resulting nanoformulation, EFPD, can target mitochondria and inhibit cell respiration to reduce O 2 consumption, thus boosting DOX‐mediated H 2 O 2 generation for enhanced CDT and simultaneously improving hypoxia‐limited DOX chemotherapy efficacy. Moreover, the coordination between EGCG and Fe 3+ provides EFPD with excellent photothermal conversion efficiencies ( η = 34.7%) for PTT and photothermal‐accelerated drug release. Experimental results indicate that EFPD‐mediated synergistic enhancement of PTT/CDT/chemotherapy can achieve excellent therapeutic outcomes, including enhanced ablation of solid tumors, reduced metastasis and cardiotoxicity, and extended life spans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, Anhui Medical University, Hefei, 230032, P. R. China.
- School of Public Health, Anhui Medical University, Hefei, 230032, P. R. China.
- School of Pharmacy, Anhui Medical University, Hefei, 230032, P. R. China.
ORCID-Profile: Tao Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Shi, H., Wang, R., Cao, H. C., Guo, H. Y., Pan, P., Xiong, C. F., Zhang, L. J., Yang, Q., Wei, S., & Liu, T. (2023). A Metal‐Polyphenol‐Based Oxygen Economizer and Fenton Reaction Amplifier for Self‐Enhanced Synergistic Photothermal/Chemodynamic/Chemotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202300054
Vancouver
Shi H, Wang R, Cao HC, Guo HY, Pan P, Xiong CF, et al. A Metal‐Polyphenol‐Based Oxygen Economizer and Fenton Reaction Amplifier for Self‐Enhanced Synergistic Photothermal/Chemodynamic/Chemotherapy. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202300054
BibTeX
@article{Shi2023,
author = {Shi, Hui and Wang, Ru and Cao, Hu-Chen and Guo, Hai-Yan and Pan, Pei and Xiong, Cheng-Feng and Zhang, Lin-Jun and Yang, Qiang and Wei, Shuang and Liu, Tao},
title = {A Metal‐Polyphenol‐Based Oxygen Economizer and Fenton Reaction Amplifier for Self‐Enhanced Synergistic Photothermal/Chemodynamic/Chemotherapy},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202300054}
}
EUVIMED